Most Alzheimer’s care focuses on managing symptoms after they appear. The ReCODE protocol takes a different approach — using comprehensive testing to identify the specific biochemical factors driving each person’s cognitive decline, then addressing them through a personalized, multi-factorial protocol.
Developed by Dr. Dale Bredesen, neurologist and Chief Scientific Officer at Apollo Health, ReCODE stands for Reversal of Cognitive Decline. This article explains how the program works, what the seven pillars of cognitive recovery involve, and who is most likely to benefit from this precision medicine approach.
Key Takeaways
- ReCODE meaning: ReCODE stands for Reversal of Cognitive Decline — a precision medicine program developed by Dr. Dale Bredesen through Apollo Health.
- Root-cause focus: Rather than only managing symptoms, ReCODE identifies and addresses the underlying biochemical contributors to memory loss.
- Multi-factorial model: The approach recognizes that cognitive decline typically results from multiple interacting factors, not a single cause. See all 36+ identified contributors.
- Personalized protocol: Comprehensive testing generates an individualized treatment plan based on each person’s unique risk factors and biomarkers.
- Seven pillars: The program combines nutrition, exercise, sleep, Stress management, Brain stimulation, detoxification, and targeted supplementation.
- Best-fit candidates: ReCODE is generally most effective for people with subjective cognitive impairment, mild cognitive impairment, or early-stage Alzheimer’s disease. Learn about early intervention.
- Structured implementation: Successful outcomes depend on organized, ongoing implementation rather than casual lifestyle changes.
What Is the ReCODE Protocol?
ReCODE is a comprehensive, personalized program designed to reverse symptoms of cognitive decline by addressing root causes rather than only managing symptoms. The name stands for Reversal of Cognitive Decline, and the approach was developed by Dr. Dale Bredesen, neurologist and Chief Scientific Officer at Apollo Health, after decades of research into the mechanisms of neurodegeneration. Instead of prescribing a single medication, ReCODE uses extensive diagnostic testing to identify each person’s specific contributors to decline, then creates a targeted protocol addressing inflammation, toxin exposure, nutrient deficiencies, and metabolic dysfunction all at once.
You might be wondering how this differs from what most doctors do. Traditional Alzheimer’s treatments typically focus on one drug targeting one pathway. ReCODE, on the other hand, treats cognitive decline as the result of many interacting factors. Two people with memory concerns might receive very different recommendations based on their individual test results.
What ReCODE Stands For
The acronym ReCODE breaks down simply: Reversal of Cognitive Decline. The name reflects the program’s central goal — actively working to reverse decline rather than simply slowing its progression.
This distinction matters more than it might seem. Traditional approaches often frame Alzheimer’s as inevitably progressive, while ReCODE operates from the premise that identifying and correcting underlying imbalances can lead to measurable cognitive improvement. Read more: Alzheimer’s Is Not a Death Sentence.
Who Developed the ReCODE Protocol
Dr. Dale Bredesen — neurologist, Chief Scientific Officer at Apollo Health, and author of The End of Alzheimer’s Program and Ageless Brain — developed the ReCODE protocol based on more than 30 years of peer-reviewed research into the mechanisms of neurodegeneration. His work is now implemented through Apollo Health, which provides the technology platform and practitioner training that supports ReCODE programs worldwide.
When we talk about “precision medicine,” we simply mean that treatment decisions are tailored to each individual based on their specific test results, genetics, and health history. It’s the opposite of a one-size-fits-all approach.
Why Cognitive Decline Has Multiple Root Causes
One of the most important insights behind ReCODE is that Alzheimer’s disease and cognitive decline rarely stem from a single cause. Dr. Bredesen’s research has identified more than 36 potential contributors that can be tested and, in many cases, addressed.
This helps explain something that has puzzled researchers for years: why have over 400 clinical drug trials targeting single mechanisms largely failed to produce breakthrough results? When decline has multiple drivers, addressing only one often isn’t enough.
Metabolic and Inflammatory Drivers
Chronic inflammation and metabolic dysfunction can impair brain function over time. The brain is highly sensitive to blood sugar regulation, and insulin resistance has been linked to increased Alzheimer’s risk.
Common metabolic and inflammatory contributors include:
- Blood sugar dysregulation: Insulin resistance affects how brain cells use energy
- Elevated inflammatory markers: Chronic inflammation damages brain tissue over time
- Hormonal imbalances: Deficiencies in thyroid, estrogen, testosterone, or other hormones affect cognition
- Poor lipid profiles: Unhealthy cholesterol levels can affect brain cell membranes
Toxin and Pathogen Exposure
Environmental exposures can contribute to cognitive decline in ways that often go undetected. Mold toxins, heavy metals like mercury or lead, and chronic infections have all been associated with brain inflammation and neurodegeneration.
The good news? Toxin exposures can be identified through testing. Once found, they can be addressed through targeted detoxification protocols.
Structural and Genetic Contributors
Vascular health directly affects brain function since the brain depends on consistent blood flow and oxygen delivery. Genetic factors — particularly carrying the APOE4 gene variant — can increase Alzheimer’s risk. However, having the gene doesn’t guarantee developing the disease.
Nutrient deficiencies also play a role, including low vitamin D, B vitamins, and omega-3 fatty acids. Many of these structural and genetic contributors are modifiable with the right interventions.
How the ReCODE Program Works
The ReCODE program follows a systematic process that moves from comprehensive testing through personalized treatment and ongoing monitoring. This isn’t a quick fix or a generic wellness plan. It’s a structured medical protocol.
1. Comprehensive Lab and Cognitive Testing
The process begins with extensive baseline testing designed to identify each person’s specific contributors to decline. Testing typically includes cognitive assessments, detailed bloodwork, genetic testing, and evaluation of inflammatory markers, hormone levels, nutrient status, and toxin exposure.
The goal is to create a complete picture of what’s happening biochemically so that treatment can be precisely targeted.
2. Personalized ReCODE Report™
Test results are analyzed through Apollo Health’s precision medicine platform, which generates an individualized ReCODE Report™. This report identifies each person’s specific contributors and provides a prioritized action plan.
Rather than generic recommendations like “eat better” or “exercise more,” the report guides exactly which interventions are most important for that individual based on their unique results.
3. Targeted Treatment Plan and Health Coaching
The treatment plan addresses each identified contributor through a combination of nutrition changes, lifestyle modifications, supplements, and sometimes medications. Education sessions help participants understand the reasoning behind each recommendation.
Health coaching supports practical implementation, covering everything from cooking training to behavior change strategies. Knowing what to do is only half the challenge — actually doing it consistently is where many people struggle.
4. Ongoing Monitoring and Plan Adjustments
ReCODE is not a one-time intervention. Regular cognitive and lab retesting tracks progress and identifies what’s working. Treatment plans are adjusted based on results, ensuring the protocol evolves as the person’s health changes.
This ongoing monitoring is essential because contributors can shift over time, and what works initially may need refinement.
The Seven Pillars of Cognitive Recovery in the ReCODE Program
The Bredesen Seven are complementary strategies designed to work together to promote neuroplasticity and support cognitive recovery. Each pillar addresses different aspects of brain health, and the combination creates synergistic effects.
1. Nutrition
KetoFLEX 12/3 is a plant-rich, mildly ketogenic eating pattern that includes time-restricted eating. The “12/3” refers to fasting at least 12 hours overnight and finishing eating at least 3 hours before bed.
This approach supports brain health by improving insulin sensitivity, reducing inflammation, and providing ketones as an alternative fuel source for brain cells.
2. Exercise
Both aerobic exercise and strength training support brain health through improved blood flow, reduced inflammation, and increased production of brain-derived neurotrophic factor (BDNF) — a protein that supports the growth of new brain cells and connections.
Exercise recommendations are tailored to each person’s current fitness level and any physical limitations.
3. Sleep Optimization
Sleep is when the brain’s glymphatic system clears toxins and waste products, including amyloid proteins associated with Alzheimer’s. Poor sleep can be both a symptom of cognitive decline and a contributor to it.
The program addresses sleep quality through evaluation of sleep disorders, sleep hygiene practices, and sometimes targeted interventions.
4. Stress Management
Chronic stress elevates cortisol, which can damage the hippocampus — the brain region critical for memory formation. The program includes specific stress-management techniques such as meditation, breathing exercises, and mindfulness practices.
5. Brain Stimulation
Brain exercises and mental stimulation help build cognitive reserve and support neuroplasticity — the brain’s ability to form new connections and adapt. Brain stimulation includes structured brain training programs, learning new skills, and engaging in mentally challenging activities.
6. Detoxification
For individuals with identified toxin exposures, the program includes protocols to support the body’s natural detoxification pathways. This might involve removing ongoing exposures, supporting liver function, and using specific binders to help eliminate toxins.
7. Targeted Supplements
Supplements are selected based on individual testing rather than generic recommendations. Depending on identified deficiencies, supplementation might include specific nutrients, hormones, or other compounds that address each person’s unique biochemical needs.
How the ReCODE Approach Differs From Traditional Alzheimer’s Care
| Factor | Traditional Care | ReCODE Approach |
| Primary goal | Manage symptoms | Address root causes |
| Treatment basis | Standard medications | Personalized protocol from testing |
| Implementation | Prescription-based | Structured lifestyle plus medical interventions |
| Monitoring | Periodic check-ins | Regular retesting and plan adjustments |
| Family involvement | Supportive role | Active participation in implementation |
Root Cause Treatment Versus Symptom Management
Traditional Alzheimer’s medications like donepezil or memantine primarily target symptoms such as memory and behavior. They may provide modest benefits but don’t address the underlying biochemical drivers of decline.
ReCODE seeks to identify and treat those underlying drivers directly, which is why testing is so central to the approach.
Personalized Plans Versus One-Size-Fits-All Drugs
Standard drug protocols give the same medication to everyone with a particular diagnosis. ReCODE recognizes that two people with cognitive decline might have completely different underlying causes and therefore need different interventions.
Structured Implementation Versus Self-Directed Lifestyle Change
Many people receive general advice to “eat better” or “exercise more” but struggle to implement meaningful changes on their own. ReCODE programs provide structure, coaching, and accountability that make consistent implementation more achievable.
This is particularly important because the protocol involves multiple simultaneous interventions that can be overwhelming without organized support.
Research and Outcomes Behind the ReCODE Protocol
Published peer-reviewed studies from Apollo Health have documented measurable cognitive improvement in participants following the ReCODE protocol. Per Apollo Health (approved outcome statistics):
- 84% of participants improved cognition in the first clinical trial of the ReCODE Program.
- 90% of participants improved in the 2025 Randomized Controlled Trial.
- The 2025 RCT — the first of its kind — found ReCODE produced statistically significant improvements in memory, executive function, processing speed, and overall cognition, with an effect size 600% greater than the leading FDA-approved Alzheimer’s drug.
It’s important to maintain realistic expectations. ReCODE is not a cure for Alzheimer’s disease, and outcomes vary based on the individual, the stage of decline, and adherence to the protocol. The approach is evidence-based, but results depend heavily on consistent implementation.
Who Is a Candidate for the ReCODE Protocol
The ReCODE program is best suited for individuals in earlier stages of cognitive decline who are medically stable enough to participate in a structured program:
- Subjective Cognitive Impairment (SCI): Self-noticed memory changes that don’t yet show up on standard testing
- Mild Cognitive Impairment (MCI): Measurable decline on cognitive tests, but daily function remains largely intact. Learn more about MCI and intervention
- Early Alzheimer’s disease: Diagnosed Alzheimer’s still in early stages. Read: Alzheimer’s Is Not a Death Sentence
Families seeking a proactive, evidence-based approach that goes beyond symptom management are typically the best fit. The program requires commitment and active participation, so motivation matters.
When Families See Cognitive Improvements on the ReCODE Program
Improvement timelines vary significantly based on the individual, the stage of decline when starting, and how consistently the protocol is followed. Some people notice changes within a few months, while others see more gradual progress over a longer period.
The program is designed as a long-term commitment — typically 12 months or more — because addressing multiple contributors and allowing the brain time to respond takes sustained effort. Quick fixes aren’t realistic when dealing with complex, multi-factorial conditions.
Starting the ReCODE Program in a Residential Setting
Implementing the full ReCODE protocol at home can be challenging. The program involves multiple daily interventions, specialized meal preparation, regular monitoring, and consistent adherence to a complex protocol.
Michigan Cognitive Recovery Center at Lakeshore Woods Senior Living in Fort Gratiot, Michigan is one of only two U.S. senior living centers that offers ReCODE+ For Facilities — the residential implementation of Dr. Bredesen’s protocol designed for 24/7 structured support. Residents receive prepared KetoFLEX meals, supervised exercise and cognitive activities, and ongoing oversight by trained ReCODE practitioners.
For families who want the benefits of the ReCODE approach but recognize the difficulty of implementing it independently, a residential setting can provide the structure and support that makes consistent adherence possible.
Does the ReCODE program cure Alzheimer’s disease?
No. ReCODE does not claim to cure Alzheimer’s disease. It is a comprehensive precision medicine approach that has shown measurable cognitive improvement in published studies by addressing root causes rather than just managing symptoms. However, outcomes vary and it is not a guaranteed cure.
How much does the ReCODE program cost?
Costs vary depending on the setting and level of support. Residential programs like Michigan Cognitive Recovery Center are designed to be more affordable than skilled nursing while providing more personalized, protocol-driven care. Families can contact us directly to discuss specific pricing and payment options.
Can the ReCODE protocol help someone with moderate or late-stage Alzheimer’s?
The ReCODE program is best suited for those in earlier stages of decline — including subjective cognitive impairment, mild cognitive impairment, and early Alzheimer’s disease. Earlier intervention typically offers the greatest potential for meaningful improvement.
Is the ReCODE protocol covered by insurance or Medicare?
Most insurance plans and Medicare do not currently cover the ReCODE program. Families considering the program can contact providers directly to discuss payment options and financial planning.
How is a ReCODE residential program different from a memory care facility?
Traditional memory care focuses primarily on safety, comfort, and symptom management. A ReCODE residential program — like MCRC at Lakeshore Woods — actively implements a precision medicine protocol aimed at improving cognitive function through structured daily interventions, specialized KetoFLEX nutrition, and ongoing medical oversight.
Disclaimer: This content is for educational purposes only and does not constitute medical advice. Treatment decisions should always be made with a qualified healthcare provider who knows the patient. The ReCODE Protocol is a precision-medicine program delivered by Apollo Health-trained practitioners and is not a cure for Alzheimer’s disease. Outcomes vary by individual. For complete clinical information, please visit Apollo Health.
About the author. This article was written by the Lakeshore Woods Team. Lakeshore Woods Senior Living is a 78-bed senior living community in Fort Gratiot Township, Michigan, and the home of Michigan Cognitive Recovery Center — one of only two U.S. senior living centers that offers the ReCODE+ For Facilities Program in partnership with Apollo Health. For complete clinical information, please visit Apollo Health.